Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Teshigawara, Sanae ^a   Wada, Jun ^a   Hida, Kazuyuki ^a   Nakatsuka, Atsuko ^a   Eguchi, Jun ^a   Murakami, Kazutoshi ^a   Kanzaki, Motoko ^a   Inoue, Kentaro ^a   Terami, Takahiro ^a   Katayama, Akihiro ^a   Iseda, Izumi ^a   Matsushita, Yuichi ^a   Miyatake, Nobuyuki ^b   McDonald, John F ^c   Hotta, Kikuko ^d   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Millipore   (United States)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROTEIN; SERPINA12 PROTEIN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; VASPIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONSENSUS; FEMALE; GENE; GENE LOCUS; GENE SEQUENCE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SERPINA12 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; SERPINS;

RATTUS;

EID: 84863572710     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3297     Document Type: Article

References (19)

1. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS 2005 Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102:10610-10615 (Pubitemid 41061602)
2. Wada J 2008 Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17:327-333 (Pubitemid 351578185)
3. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, Jang HC, Kim MS 2011 Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 75:628-635
4. Cho JK, Han TK, Kang HS 2010 Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 108:347-353
5. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Blüher M 2008 Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57:372-377
6. Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, Chu SH, Chung KM, Lee HC, Oh EG, Kim SH, Jeon JY 2010 Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 411:381-385
7. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, Abaci A 2009 Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 84:325-328
8. Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D 2011 The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 58:237-246
9. Cakal E, Ustun Y, Engin-Ustun Y, Ozkaya M, Kilinç M2011 Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 27:491-495
10. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS 2008 Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57:1501-1507
11. Handisurya A, Riedl M, Vila G, Maier C, Clodi M, Prikoszovich T, Ludvik B, Prager G, Luger A, Kautzky-Willer A 2010 Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 20:198-203
12. Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, Jang YJ 2010 Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 18:2105-2110
13. Oberbach A, Kirsch K, Lehmann S, Schlichting N, Fasshauer M, Zarse K, Stumvoll M, Ristow M, Blüher M, Kovacs P 2010 Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes Facts 3:328-331
14. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C 1987 Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80:458-465
15. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM 1987 cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330:132-137 (Pubitemid 17158542)
16. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS 2000 Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134-138
17. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, Meisinger C, Wichmann HE, Herder C, Vollmert C 2010 Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocrinol Diabetes 118:184-189
18. Seeger J, Ziegelmeier M, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M 2008 Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93:247-251
19. Hida K, Poulsen P, Teshigawara S, Nilsson E, Friedrichsen M, Ribel-Madsen R, Grunnet L, Lund SS, Wada J, Vaag A 2012 Impact of circulating vaspin levels on metabolic variables in elderly twins. Diabetologia 55:530-532